Form 8-K - Current report:
SEC Accession No. 0000950170-21-000510
Filing Date
2021-07-23
Accepted
2021-07-22 21:01:52
Documents
13
Period of Report
2021-07-21
Items
Item 1.01: Entry into a Material Definitive Agreement
Item 9.01: Financial Statements and Exhibits

Document Format Files

Seq Description Document Type Size
1 8-K kod-20210721.htm   iXBRL 8-K 49454
2 EX-10.1 kod-20210721ex10_1.htm EX-10.1 18008
  Complete submission text file 0000950170-21-000510.txt   184123

Data Files

Seq Description Document Type Size
3 XBRL TAXONOMY EXTENSION LABEL LINKBASE DOCUMENT kod-20210721_lab.xml EX-101.LAB 12936
4 XBRL TAXONOMY EXTENSION SCHEMA DOCUMENT kod-20210721.xsd EX-101.SCH 2420
5 XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE DOCUMENT kod-20210721_pre.xml EX-101.PRE 9578
6 EXTRACTED XBRL INSTANCE DOCUMENT kod-20210721_htm.xml XML 4514
Mailing Address 1200 PAGE MILL RD PALO ALTO CA 94304
Business Address 1200 PAGE MILL RD PALO ALTO CA 94304 650-281-0850
Kodiak Sciences Inc. (Filer) CIK: 0001468748 (see all company filings)

EIN.: 270476525 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 8-K | Act: 34 | File No.: 001-38682 | Film No.: 211108870
SIC: 2836 Biological Products, (No Diagnostic Substances)